Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7952 results

Sort By:

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Study ID: NCT05361720
Start Date: 2022-12-01
End Date: 2026-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

54

Intervention / Treatment

Cabozantinib

Ipilimumab

Nivolumab

Sponsor

Vanderbilt-Ingram Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

Study ID: NCT05812274
Start Date: 2023-04
End Date: 2025-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

280

Intervention / Treatment

Apricity C.A.R.E. Program for Cancer Adverse events Rapid Evaluation

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Study ID: NCT04365374
Start Date: 2021-04-06
End Date: 2027-12-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

180

Intervention / Treatment

Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)

Stereotactic Radiation Therapy

Sponsor

GT Medical Technologies, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Study ID: NCT06632327
Start Date: 2024-12-11
End Date: 2030-04-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1100

Intervention / Treatment

Surgical Procedure

Cisplatin

Carboplatin

Pemetrexed

Gemcitabine

Docetaxel

Vinorelbine

Nivolumab

Pembrolizumab

Atezolizumab

Computed Tomography

Magnetic Resonance Imaging

Positron Emission Tomography

Sponsor

Alliance for Clinical Trials in Oncology

Source: clinicaltrials.gov

Share:
Add to list

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Study ID: NCT06607627
Start Date: 2024-12-23
End Date: 2029-07-18
Study Type

Interventional

Study Phase

Phase3

No. of Participants

12

Intervention / Treatment

Gefurulimab

Sponsor

Alexion Pharmaceuticals, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Study ID: NCT04573231
Start Date: 2021-05-24
End Date: 2025-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

13

Intervention / Treatment

18F-DCFPyL

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Study ID: NCT03206060
Start Date: 2017-10-10
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

130

Intervention / Treatment

LU-177-Dotate

Ga-68-Dotate

F-18-FDG

Amino Acid solution

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Study ID: NCT04919382
Start Date: 2022-01-26
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

56

Intervention / Treatment

Atezolizumab

Temozolomide

Sponsor

Dwight Owen

Source: clinicaltrials.gov

Share:
Add to list

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Study ID: NCT03537482
Start Date: 2018-08-07
End Date: 2025-02-15
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

90

Intervention / Treatment

APG-2575

Sponsor

Ascentage Pharma Group Inc.

Source: clinicaltrials.gov

Share:
Add to list

Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Study ID: NCT06106282
Start Date: 2023-07-12
End Date: 2028-07-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Non-Interventional Study

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list